Article citationsMore>>
Ohe, Y., Ichinose, Y., Nakagawa, K., Tamura, T., Kubota, K., Yamamoto, N., Adachi, S., Nambu, Y., Fujimoto, T., Nishiwaki, Y., Saijo, N. and Fukuoka, M. (2008) Efficacy and Safety of Two Doses of Pemetrexed Supplemented with Folic Acid and Vitamin B12 in Previously Treated Patients with Non-Small Cell Lung Cancer. Clinical Cancer Re- search, 14, 4206-4212. http://dx.doi.org/10.1158/1078-0432.CCR-07-5143
has been cited by the following article:
-
TITLE:
Good Response to Pemetrexed after Treatment Failure with Another Thymidylate Synthase Inhibitor in Lung Adenocarcinoma: A Case Report
AUTHORS:
Fumihiko Hirai, Eiko Inamasu, Gouji Toyokawa, Tsukihisa Yoshida, Kaname Nosaki, Tomoyoshi Takenaka, Masafumi Yamaguchi, Mitsuhiro Takenoyama, Takashi Seto, Yukito Ichinose
KEYWORDS:
Pemetrexed, S-1, Thymidylate Synthase
JOURNAL NAME:
Journal of Cancer Therapy,
Vol.5 No.8,
July
10,
2014
ABSTRACT:
Pemetrexed is an
antimetabolic agent and is well-known as a potent inhibitor of thymidylate
synthase (TS). It also inhibits dihydrofolate reductase (DHFR) and glycinamide
ribonucleotide formyl transferase (GARFT). We reported an intriguing case in
which a non-small cell lung cancer patient who was refractory to pretreatment
with S-1, a strong TS inhibitor, showed good response to pemetrexed treatment.
Related Articles:
-
Sopita Khamrod
-
Narottam S. Regmi, Brett L. Heber, James W. Klena
-
Yuki Katsuya, Yuichiro Takeda, Go Naka, Haruhito Sugiyama
-
Saé Muñiz-Hernández, Norma Hernández-Pedro, Omar E. Macedo-Pérez, Oscar Arrieta
-
Thomas Bauernhofer, Helmut Samonigg, Peter Regitnik, Werner Weitzer, Brigitte Lileg, Günter Waxenecker, Susanne Wiederkum, Manuela Kainer, Manfred Schuster, Hans Loibner, Markus Fido, Ralf Kircheis, Andreas Nechansky